General
Preferred name
STANOLONE
Synonyms
dihydrotestosterone ()
androstanolone ()
androstanolone, stanolone, 5α-DHT ()
androstanolone, stanolone, 5??-DHT ()
[3H]dihydrotestosterone ()
4-dihydrotestosterone ()
Andractim ()
Dihydrotestosterone (DHT) ()
NSC-10972 ()
Neodrol ()
Anabolex ()
5alpha-dihydrotestosterone ()
Dihydrotestosterone ()
P&D ID
PD012320
CAS
521-18-6
12040-51-6
Tags
natural product
drug
available
Drug indication
Prostate hyperplasia
Drug Status
illicit
investigational
approved
Max Phase
Phase 2
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Dihydrotestosterone is an androgenic metabolite of testosterone, it is the primary contributing factor in male pattern baldness.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
14
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
NURSA ligand set
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
55
Molecular Weight
290.22
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
0
cLogP
3.96
TPSA
37.3
Fraction CSP3
0.95
Chiral centers
7.0
Largest ring
6.0
QED
0.73
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
